Kevin White
Executive Director, BI Venture Fund Boehringer Ingelheim
Seminars
Wednesday 9th September 2026
Scientific, Operational & Economic Realities for Immune-Modulating Therapies: What Have we Learnt so Far?
11:40 am
- Pharma’s reflections on recent in vivo CAR-T deals, what data was valuable when clinical data was minimal?
- Overlapping and diverging advantages of TCEs to in vivo CAR-T, including depth and durability of response.
- Debating clinical-adjacent innovations in delivery across viral vectors and LNPs and their application in immunology versus oncology
Wednesday 9th September 2026
Presentation Session One: Showcase Your Science
1:45 pm
Present your company’s slides by securing a 15-minute presentation slot in front of the attending audience, within this track.
Thursday 10th September 2026
Investor Introduction Tables: Sit, Connect & Break the Ice
12:00 pm
Starting with a short investor panel introducing investor interests and moving into an organised networking session.
Mirroring the Pharma Introduction Tables, select the investors that best align with your organisation’s stage and objectives, and join their networking table for 30-minutes. Share business cards or ask a followup question from the panel with your target investor to tick off another key connection at the conference.
